GL1X · GenesisL1 explorer

Research workbench

JAK2 JH1 in complex with fedratinib

Analyse JAK2 JH1 in complex with fedratinib in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6VNE
Type
protein
Length
581 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK2
EC
2.7.10.2
UniProt
O60674
Ligands
2TA
Pockets
6 · best druggability 0.75

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BTyrosine-protein kinase JAK2 (EC 2.7.10.2)protein28941% helix, 19% strandO60674
ATyrosine-protein kinase JAK2 (EC 2.7.10.2)protein29241% helix, 19% strandO60674

Ligands and binding sites

  • 2TA · N-tert-butyl-3-{[5-methyl-2-({4-[2-(pyrrolidin-1-yl) ethoxy]phenyl}amino)pyrimidin-4-yl]amino}benzenesulfonamide · ligand · 2 copies · chains B, A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17430.750.8062empty
26720.730.79612TA
36000.720.80542TA
4670.370.7816empty
5610.290.7421empty

Interfaces

1 interface between chains.

  • B–A · 457 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified (phosphorylation).

Compared structures

  • 6VNE · JAK2 JH1 in complex with Fedratinib · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.